AA
TNDM icon

AlphaCentric Advisors’s Tandem Diabetes Care TNDM Stock Holding History

AlphaCentric Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$292K Buy
+8,105
New +$274K 0.29% 90

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCentric Advisors's TNDM Position: Q4 2024 in Review

AlphaCentric Advisors opened a new position in Tandem Diabetes Care (TNDM) in Q4 2024: 8,105 shares worth $292K. The stake represents 0.29% of the portfolio and ranks #90 among its holdings.

316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • AlphaCentric Advisors held 8,105 shares of Tandem Diabetes Care worth $292K as of Q4 2024.
  • Tandem Diabetes Care was a new AlphaCentric Advisors position in Q4 2024.
  • Tandem Diabetes Care made up 0.29% of AlphaCentric Advisors's portfolio in Q4 2024, its #90 holding.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.